Study shows close link between cytokine interleukin-1ß and obesity-promoted colon cancer

NewsGuard 100/100 Score

A new study describes the mechanistic relationship between the cytokine interleukin-1β, (IL-1β) and obesity, showing that when IL-1β levels are increased in obesity, IL-1 receptor signaling activates multiple pathways leading to colon cancer. The study shows that obesity is linked with systemic increases in IL-1β, activation of Wnt, and proliferation of mouse colon cells, as reported in an article published in Journal of Interferon & Cytokine Research (JICR) from Mary Ann Liebert, Inc., publishers.

Joel Mason, Tufts University and Tufts University School of Medicine, Boston MA, and colleagues from Tufts University, coauthored the article entitled "Interleukin-1 Signaling Mediates Obesity-Promoted Elevations in Inflammatory Cytokines, Wnt Activation, and Epithelial Proliferation in the Mouse Colon."

The researchers set out to define the role of IL-1β in mediating the events leading up to obesity-promoted colorectal cancer. They compared the role of IL-1β in mice fed either a high-fat (obese) or low-fat (lean) diet. Among the changes they found were that obese mice had 30-80% greater concentrations of IL-1β in the colonic mucosa, a significant increase in the Wnt signaling cascade, and a significant expansion in the proliferation zone of the colonic crypt.

"This study reveals the close linkage of obesity and the inflammatory response and reflects the broad actions of IL-1β that define obesity as one of many inflammatory diseases," says Journal of Interferon & Cytokine Research Editor-in-Chief Michael Gale Jr., Department of Immunology, University of Washington, Center for Innate Immunity and Immune Disease.

Source: https://home.liebertpub.com/news/cytokine-mediates-obesity-related-factors-linked-to-colorectal-cancer/2458

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Triple-negative breast cancer patients with high immune cell levels have lower relapse risk after surgery